Medicine News and Research

RSS

Treatment with imatinib results in lower mortality rates for patients with severe COVID-19

Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international conference.

18 May 2022

New, minimally invasive biomarker-based strategy 90% successful in detecting esophageal cancer

In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal squamous cell carcinoma (ESCC), the predominant subtype of esophageal cancer worldwide.

18 May 2022

Researchers show the feasibility of a comprehensive sequencing approach in pediatric and young adult cancers

New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a comprehensive sequencing approach on 114 pediatric, adolescent, and young adult patients with solid tumors.

18 May 2022

High-risk prescribing practices associated with increased risk of disability among older adults

For many, good health and longevity is only achievable with the help of prescription drugs. However, researchers in Japan have recently identified that some "high-risk" prescribing practices may be a cause for concern among older adults.

18 May 2022

Children's Colorado first in the world to implant the newly FDA-approved G-Armor Stent

Children's Hospital Colorado (Children's Colorado) is the first hospital in the world to implant the newly FDA-approved G-Armor Stent. Although the stent is designed to be used in the smallest of patients, it was first implanted in a Colorado father of two.

18 May 2022

‘That’s just part of aging’: Long covid symptoms are often overlooked in seniors

Nearly 18 months after getting covid-19 and spending weeks in the hospital, Terry Bell struggles with hanging up his shirts and pants after doing the laundry.

18 May 2022

How better ventilation can help ‘covid-proof’ your home

For two years, you beat the odds. You masked, kept your distance, got your shots.

18 May 2022

3D printed masks versus N95 masks against COVID-19

Researchers assessed 3D printed masks as an alternative to N95 respirators against SARS-CoV-2.

18 May 2022

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

A research team at LKS Faculty of Medicine, The University of Hong Kong discovered that exosomes derived from γδ-T cells (γδ-T-Exos) synergised with radiotherapy can control nasopharyngeal carcinoma (NPC) by overcoming the radioresistance of NPC cancer stem cells (CSCs) and preserve their tumor-killing and T cell-promoting activities in the immunosuppressive NPC microenvironment.

18 May 2022

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors.

18 May 2022

Study shows why COPD patients are more vulnerable to severe COVID-19

Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19.

18 May 2022

NYU Long Island School of Medicine celebrates first graduating class of primary care physicians

NYU Long Island School of Medicine today celebrates its first graduating class of physicians, marking three years since the medical school opened its doors, launching the nation's first accelerated MD program devoted exclusively to training primary care physicians.

17 May 2022

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

Researchers from Naval Medical University have been investigating anisodamine, used in traditional Chinese medicine, to inhibit SARS-CoV-2 infection in cellular models. The study is published in the journal Biochemical and Biophysical Research Communications.

17 May 2022

Poll: Most people over 50 feel their health is the same or better than before 2020

Despite the pandemic's terrible toll on older adults, a new national poll shows that most people over 50 still say their health is as good as it was before March 2020, or even better.

17 May 2022

Scientists use machine learning models to help discern characteristics of people with long-COVID

Clinical scientists used machine learning (ML) models to explore de-identified electronic health record (EHR) data in the National COVID Cohort Collaborative (N3C), a National Institutes of Health-funded national clinical database, to help discern characteristics of people with long-COVID and factors that may help identify such patients using data from medical records.

17 May 2022

Community-focused model improves equitable access to COVID-19 vaccination

New research from Boston Medical Center (BMC) shows how intentionality and partnership between community leaders and medical health centers can improve COVID-19 vaccination uptake in Black and Latino communities.

17 May 2022

Researchers discover how Type I interferon stops the immune system 'going rogue' during viral infections

McMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.

17 May 2022

COVID-19 has exacerbated adolescent mental health crises and suicidality

The past decade has seen a worrisome increase in mental health crises among adolescents. A new study led by Patricia Ibeziako, MD, associate chief of clinical services in the Department of Psychiatry and Behavioral Services at Boston Children's Hospital, shows that the situation worsened with the onset of the COVID-19 pandemic.

17 May 2022

Experimental drug more effective than existing FDA-approved medications for ALS

New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease.

17 May 2022

Multi-country study provides a clear treatment option for IgA nephropathy

The largest ever randomized controlled trial in IgA nephropathy has found that treatment with methylprednisolone - a cheap, widely used corticosteroid drug - halves the risk of losing kidney function and kidney failure, and that this can be effectively achieved with fewer side effects if a reduced dose is used.

17 May 2022

Medicine News and Research

Treatment with imatinib results in lower mortality rates for patients with severe COVID-19

New, minimally invasive biomarker-based strategy 90% successful in detecting esophageal cancer

Researchers show the feasibility of a comprehensive sequencing approach in pediatric and young adult cancers

High-risk prescribing practices associated with increased risk of disability among older adults

Children's Colorado first in the world to implant the newly FDA-approved G-Armor Stent

‘That’s just part of aging’: Long covid symptoms are often overlooked in seniors

How better ventilation can help ‘covid-proof’ your home

3D printed masks versus N95 masks against COVID-19

Exosomes derived from γδ-T cells synergized with radiotherapy can control nasopharyngeal carcinoma

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Study shows why COPD patients are more vulnerable to severe COVID-19

NYU Long Island School of Medicine celebrates first graduating class of primary care physicians

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

Poll: Most people over 50 feel their health is the same or better than before 2020

Scientists use machine learning models to help discern characteristics of people with long-COVID

Community-focused model improves equitable access to COVID-19 vaccination

Researchers discover how Type I interferon stops the immune system 'going rogue' during viral infections

COVID-19 has exacerbated adolescent mental health crises and suicidality

Experimental drug more effective than existing FDA-approved medications for ALS

Multi-country study provides a clear treatment option for IgA nephropathy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News